MEK2, an upstream kinase in the ERK signaling pathway, undergoes O‐GlcNAcylation at Thr13, which promotes Thr394 autophosphorylation, enhancing MEK2 stability and activation, thereby driving breast cancer cell proliferation. Here, MAP2K2 is linked to breast cancer.